Cynata Therapeutics Limited
ASX:CYP.AX
0.19 (AUD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||
| Net Income
| -9.745 | -14.277 | -5.445 | -7.69 | -3.639 | -8.472 | -4.566 | -4.554 | -4.939 | -3.712 | -3.04 | -0.916 | -1.542 | -2.565 | -2.116 | -1.45 | -2.035 |
| Depreciation & Amortization
| 0.281 | 0.28 | 0.28 | 0.28 | 0.281 | 0.28 | 0.28 | 0.28 | 0.281 | 0.448 | 0 | 0 | 0.413 | 0.01 | 0.003 | 0.005 | 0.006 |
| Deferred Income Tax
| 0 | -1.503 | -0.62 | -1.513 | -1.579 | -0.945 | 0.028 | -0.216 | -0.228 | -0.391 | -1.326 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0.327 | 1.032 | 1.537 | 0.388 | 0.904 | 0.274 | 0.249 | 0.238 | 0.429 | 1.303 | 0.069 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -0.726 | -0.684 | 1.007 | 0.755 | -0.615 | 0.041 | -0.303 | -0.033 | -0.01 | -0.038 | 0.024 | -0.009 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables
| 0.363 | -0.356 | 0.02 | -0.157 | 0.152 | 0.041 | -0.303 | -0.033 | -0.01 | -0.038 | 0.024 | -0.009 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -0.554 | -0.312 | 0.058 | -0.105 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.117 | -0.26 | 0.952 | 0.741 | -0.781 | 0.534 | 0.295 | -0.008 | 0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0.028 | -0.068 | 0.035 | 0.171 | 0.014 | 0.021 | 0.017 | 0.008 | -0.08 | 0.011 | -0.076 | -0.007 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 1.545 | 1.575 | 0.448 | 1.467 | 1.776 | 1.433 | 0.224 | 0.009 | 0.077 | 0.271 | -0.141 | 0.09 | 1.129 | 2.555 | 2.113 | 1.446 | 2.029 |
| Operating Cash Flow
| -9.961 | -14.283 | -3.298 | -5.163 | -3.388 | -6.759 | -4.062 | -4.048 | -4.354 | -2.602 | -1.854 | -0.766 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities: | |||||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | -0.015 | -0.091 | -0.06 | -0.041 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.159 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.271 | -0.746 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.271 | -0.746 | 0 | 0 | 0 | 0.002 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.112 | -0.746 | -0.001 | -0.015 | -0.091 | -0.058 | -0.041 |
| Financing Activities: | |||||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.02 | -0.033 | -0.016 | 0 | 0 |
| Common Stock Issued
| 0 | 6.724 | 0 | 17.735 | 8.975 | 1.33 | 5.858 | 9.586 | 4.535 | 2.222 | 6.44 | 1.75 | 1.354 | 2.416 | 1.656 | 0.202 | 2.773 |
| Common Stock Repurchased
| 0 | -0.318 | 0 | -0.572 | -0.407 | -0.076 | -0.13 | -0.386 | -0.465 | -0.044 | -0.496 | -0.114 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.318 | 0.21 | 1.034 | 1.492 | 0.276 | 0.13 | 0.386 | 0.465 | 2.179 | 5.944 | 1.636 | 0 | 0.048 | 0.027 | 0 | 0 |
| Financing Cash Flow
| 0 | 6.724 | 0.21 | 18.197 | 10.06 | 1.53 | 5.858 | 9.586 | 4.535 | 2.179 | 5.944 | 1.636 | 1.334 | 2.431 | 1.667 | 0.202 | 2.773 |
| Other Information: | |||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | -0.072 | 0.17 | 0.033 | -0 | 0 | 0.06 | -0.067 | 0.028 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -9.962 | -7.631 | -2.919 | 13.067 | 6.672 | -5.229 | 1.856 | 5.471 | 0.208 | -0.424 | 3.978 | 0.124 | 0.604 | -0.238 | -0.377 | -1.074 | 1.296 |
| Cash At End Of Period
| 6.205 | 16.167 | 23.798 | 26.717 | 13.65 | 6.977 | 12.206 | 10.35 | 4.879 | 4.671 | 5.095 | 1.117 | 0.993 | 0.389 | 0.628 | 1.005 | 2.079 |